Because recent discoveries have the potential to change the paradigm for how both MPN and MDS are diagnosed and treated, it is imperative that HCPs are provided an expert review for optimal integration into everyday clinical practice.
Alexandria, VA (PRWEB) August 16, 2016
Educational, informative and clinically-relevant, the US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes will be held at the Westin Alexandria (400 Courthouse Sq., Alexandria, VA 22314) on August 26-27, 2016.
Organized by Imedex, an industry leader in providing certified, independent medical education to health care professionals, and chaired by Srdan Verstovsek, MD, PhD, and Guillermo Garcia-Manero, MD, Chiefs of the Section for Myeloproliferative Neoplasms and Section of Myelodysplastic Syndromes, respectively at the prestigious MD Anderson Cancer Center, this conference will provide a dynamic platform addressing many of the clinical challenges related to the diagnosis and treatment of MPN and MDS.
“The knowledge that attendees gain from this meeting will help them implement new methods and strategies for diagnosis, risk stratification, and medical management—strategies that lead to the enhancement in clinical outcomes and quality of life for patients with MPN and MDS,” said Dr. Verstovsek.
With few other meetings of this type currently in the United States, this highly-relevant clinical conference will provide the basis to advance understanding, drive optimal use of therapeutic strategies, and improve patient outcomes for MPN and MDS. The diverse mix of didactic presentations and interactive discussion, will ensure that attendees have the opportunity to strengthen their knowledge in the field, confirm current practices, and receive valuable take-home information as it relates to new screening and staging modalities, management approaches and emerging treatment options.
“Because recent discoveries have the potential to change the paradigm for how both MPN and MDS are diagnosed and treated, it is imperative that healthcare professionals who care for these patients are provided an expert review of the most pertinent clinical data on prognosis, diagnosis, therapy and disease management for optimal integration into everyday clinical practice,” said Dr. Garcia-Manero.
Offering ACCME accreditation and MOC points, this conference is intended to meet the educational needs of hematologists, medical oncologists and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physician assistants, etc.) who are involved and/or interested in the treatment of patients with MPN and MDS.
Registration discounts are available when registering in advance. For more information, visit http://www.mdsmpncongress.com.
Imedex is the industry leader in developing and delivering independent, accredited health care education. The Company’s programs, specializing in oncology, hematology, and gastroenterology, are provided through live events around the world, as well as effective online educational opportunities for on-the-go healthcare providers.
Imedex’s high quality scientific programming translates the latest research into clinically-relevant information. Our activities address the needs of healthcare professionals inundated by information through exceptional organization and outstanding educational value, with a proven sustained impact on patient care.
With a global footprint in the United States, Europe and Asia, Imedex provides over 50,000 E-learning experiences annually and its live conferences have interfaced with more than 100,000 attendees from 29 countries, since 2001.